This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
Menu
Follow UroToday
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
        • Kidney Cancer
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Daniel George, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mCRPC Treatment
          Charles Ryan, MD
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Neal Shore, MD, FACS
        • A Patient Journey
          Alicia Morgans, MD, MPH
          Charles J. Ryan, MD
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
  • Transformative Evidence
    • mCRPC
      • CARD Trial
      • PROfound Study
    • mHSPC
      • ENZAMET Trial
    • nmCRPC
      • PROSPER Trial
    • Advanced Prostate Cancer
      • HERO Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Videos
    • Conference Coverage and Experts Group
      • Interviews with Experts at Conferences
        • ASCO 2019
        • ASCO 2020
        • ASCO GU 2020
        • ESMO 2020
      • Exclusive Collaborations
        • APCCC 2019
        • LUGPA Annual Meeting 2019
        • PCF 2019
        • SNMMI Curriculum
      • UroToday Exclusives
        • A Step Towards Personalized Medicine: PSMA PET Imaging in Prostate Cancer
        • Book Club
        • Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer
        • COVID-19 and Genitourinary Cancers Videos
        • Large Urology Group Practice Association (LUGPA)
        • Precision Medicine: PSMA Targeted Therapies in Progressive Metastatic Prostate Cancer Videos
    • Urologic Oncology
      • Bladder Cancer
        • Bladder Cancer
        • Bladder Cancer Expert Debates
        • Advanced Bladder Cancer
        • Non-Muscle Invasive Bladder Cancer
      • Kidney Cancer
        • Advanced Kidney Cancer
        • Renal Cancer
      • Prostate Cancer
        • Advances in Nuclear Medicine, PET, and Theranostics
        • Advanced Prostate Cancer
        • Cardiovascular Disease in Men with Prostate Cancer
        • CRPC with Bone Metastases
        • The Expert Voice
        • Imaging: Prostate Cancer
        • Localized Prostate Cancer
        • mCRPC
        • mHSPC
        • Molecular Diagnostics
        • Navigating Cancer
        • nmCRPC
        • The Patient Voice
        • Precision Medicine in Prostate Cancer
        • Prostate Cancer
      • Upper Tract Urothelial Tumors
        • Upper Tract Urothelial Carcinoma
    • Pelvic Health & Reconstruction
      • Bladder Health
      • Indwelling Catheters
      • Intermittent Catheters
      • Nocturia & Lower Urinary Tract Conditions
    • Endourology
      • Endourology Today
      • Endourology
  • Journals
    • Everyday Urology - Oncology Insights
      Everyday Urology - Oncology Insights
      • From the Editor
      • Current Issue
      • Previous Issues
    • Prostate Cancer and Prostatic Diseases
      Prostate Cancer and Prostatic Diseases
      • From the Editor
      • Current Article
      • Previous Articles
  • Clinical Trials
    • Clinical Trials
      • Search Clinical Trials
    • From the Editor
      • Current Letter
      • Previous Letters
  • Conference Coverage
    • Advanced Prostate Cancer Consensus Conference (APCCC)
      • 2019 APCCC Meeting
    • American Society of Clinical Oncology (ASCO)
      • 2020 Virtual Education Program
      • 2020 Annual Meeting
      • 2020 ASCO GU Symposium
      • 2019 Annual Meeting
      • 2019 ASCO GU Symposium
    • American Urological Association (AUA)
      • 2020 Annual Meeting
      • 2019 Annual Meeting
    • ANZUP Mini Annual Scientific Meeting (ASM)
      • 2020 Virtual Annual Meeting
    • Bladder Cancer Advocacy Network (BCAN)
      • 2020 Think Tank Virtual Program
      • 2019 Think Tank
    • Canadian Urological Association (CUA)
      • 2019 CUOS Summit
    • Clinical Conference
      • 2019 American College of Surgeons
    • EMUC
      • 2020 Annual Meeting
    • European Association of Urology (EAU)
      • 2020 Annual Congress
      • 2019 Annual Congress
      • ESOU 2019
    • Enhanced Recovery After Surgery (ERAS)
      • 2019 ERAS Annual Congress
    • European Society for Medical Oncology (ESMO)
      • 2020 Virtual Congress
      • 2019 Annual Congress
    • Global Society of Rare GU Tumors
      • 2020 Meeting
    • International Bladder Cancer Network (IBCN)
      • 2020 Annual Virtual Meeting
      • 2019 Meeting
    • Prostate Cancer Academy
      • 2020 Annual Meeting
    • Société Internationale d'Urologie (SIU)
      • 2020 Annual Congress
      • 2019 Annual Congress
    • Society of Nuclear Medicine and Molecular Imaging (SNMMI)
      • 2019 Therapeutics Conference
    • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
      • 2020 Congress
      • 2019 Congress
    • Society of Urologic Oncology (SUO)
      • 2020 Annual Meeting
      • 2020 SUO - AUA Summer Webcast
      • 2019 Annual Meeting
    • Targeted Alpha Therapy (TAT)
      • 2019 Symposium
    • World Congress of Endourology and SWL (WCE)
      • 2019 Annual Meeting
  • Articles
    • Urologic Oncology
      • Adrenal Diseases
      • Bladder Cancer
      • CRPC w/ Bone Metastases
      • Penile Cancer
      • Prostate Cancer
      • Renal Cancer
      • Testicular Cancer
      • Upper Tract Tumors
      • Investigative Urology
    • Men's Health
      • Androgen Deficiency
      • BPH
      • Erectile Dysfunction
      • Male Infertility
      • Peyronie’s Disease
      • Prostatitis
      • Vasectomy
    • Pelvic Health & Reconstruction
      • Fecal Incontinence
      • Fistula
      • GU Trauma & Reconstruction
      • Indwelling Catheters
      • Infections
      • Intermittent Catheters
      • Interstitial Cystitis
      • Neurogenic Bladder
      • Nocturia
      • Overactive Bladder
      • Pelvic Prolapse
      • Post-prostatectomy Incontinence
      • Stress Incontinence
      • Underactive Bladder
      • Urethral Strictures
      • Urinary Incontinence
      • Urinary Retention
      • Urinary Tract Infection – CAUTIs
      • Urologic Catheters
    • Endourology & Urolithiasis
      • Minimally Invasive Procedures
      • Stone Disease
    • Pediatric Urology
      • Pediatric Urology
    • COVID-19 and Genitourinary Cancers
      • COVID-19 and Genitourinary Cancers
  • Calendar
  1. UroToday Home
  2. Conference Highlights

ASCO GU 2019

  • Prostate Cancer
  • Kidney Cancer
  • Bladder Cancer
  • Penile, Urethral, Testicular, and Adrenal Cancers
  • Press Releases

ASCO GU 2019

ASCO GU 2019

  • ASCO GU 2019: LATITUDE Study - Final Analysis of Phase III Study in Patients with Newly Diagnosed High-Risk Metastatic Castration-Naïve Prostate Cancer
  • ASCO GU 2019: Transitional Surrogate Endpoint for Survival in Phase II Trials for mCRPC - Assessment of Circulating Tumor Cell Number
  • ASCO GU 2019: Initial Results from a Phase II Study of Nivolumab plus Ipilimumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer - CheckMate 650
  • ASCO GU 2019: Pembrolizumab in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer
  • ASCO GU 2019: PROSPER: Comparing Perioperative Nivolumab versus Observation in Patients with Localized Renal Cell Carcinoma Undergoing Nephrectomy
View all (47 articles)

ASCO GU 2019 Kidney Cancer

  • ASCO GU 2019: Results from KEYNOTE-427 Cohort B: First-line Pembrolizumab Monotherapy for Advanced Non-Clear Cell Renal Cell Carcinoma
  • ASCO GU 2019: Phase III KEYNOTE-426 Study: Pembrolizumab plus Axitinib versus Sunitinib as First-Line Therapy for Locally Advanced or Metastatic Renal Cell Carcinoma
  • ASCO GU 2019: Phase III CheckMate 214 Trial of First-Line Nivolumab + Ipilimumab or Sunitinib in Patients with Advanced Renal Cell Carcinoma with Thirty Month Follow Up Results
  • ASCO GU 2019: Final analysis from the NIVOREN GETUG AFU 26 study — Safety and Efficacy of Nivolumab in Metastatic Renal Cell Carcinoma
  • ASCO GU 2019: CheckMate 214 Trial - Thirty Month Follow-up of First-line Nivolumab + Ipilimumab or Sunitinib in Patients with Advanced Renal Cell Carcinoma
View all (52 articles)

ASCO GU 2019 Bladder Cancer

  • ASCO GU 2019: Phase II Trial of Pembrolizumab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to BCG
  • ASCO GU 2019: PIVOT-02 Study of NKTR-214 with Nivolumab in Metastatic Urothelial Carcinoma
  • ASCO GU 2019: Gemcitabine-Carboplatin versus Gemcitabine-Oxaliplatin In Cisplatin Un-Fit Advanced Urothelial Carcinoma: Randomized Phase II Study-COACH Study
  • ASCO GU 2019: CheckMate 9UT - Nivolumab or Nivo Plus BMS-986205 with or without Intravesical Bacillus Calmette-Guerin in BCG-Unresponsive, High-Risk, Non-Muscle Invasive Bladder Cancer
  • ASCO GU 2019: POTOMAC Study - Durvalumab and BCG versus BCG Alone in High-risk, BCG-Naïve Non Muscle-Invasive Bladder Cancer
View all (26 articles)

ASCO GU 2019 Penile, Urethral, Testicular, and Adrenal Cancers

  • ASCO GU 2019: Fierce-21: Phase II Study of Vofatamab, a Selective Inhibitor of FGFR3, as Salvage Therapy in Metastatic Urothelial Carcinoma
  • ASCO GU 2019: Health-Related Quality of Life Reporting in Phase III Randomized Controlled Trials of Metastatic Prostate Adenocarcinoma and Urothelial Carcinoma
  • ASCO GU 2019: Study of Durvalumab Given with Chemotherapy, Durvalumab in Combination with Tremelimumab Given with Chemotherapy, or Chemotherapy in Patients with Unresectable Locally Advanced or Metastatic Urothelial Cancer
  • ASCO GU 2019: Phase II Study of Ribociclib in Men with Unresectable, Incurable Teratoma with Recent Progression
  • ASCO GU 2019: Accelerated versus Standard BEP Chemotherapy for Adult and Pediatric Male and Female Patients with Intermediate and Poor-Risk Metastatic Germ Cell Tumors
View all (17 articles)

ASCO GU 2019 Press Releases

  • Seattle Cancer Care Alliance Physicians to Present their Research at Genitourinary Cancers Symposium
  • ASCO GU 2019: Phase 3 Study of Androgen Deprivation Therapy with Enzalutamide or Placebo in Metastatic Hormone-Sensitive Prostate Cancer: The ARCHES Trial
  • MDxHealth Announces Presentation of Positive Data for SelectMDx and ConfirmMDx in Prostate Cancer Diagnosis
  • ARAMIS: Efficacy and Safety of Darolutamide in nmCRPC | ASCO GU 2019
  • Phase 3 ARCHES Trial Shows XTANDI® (enzalutamide) Significantly Improved Radiographic Progression-Free Survival in Men with Metastatic Hormone-Sensitive Prostate Cancer
View all (9 articles)
  • About UroToday
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use

COPYRIGHT © 2002 - 2021 DIGITAL SCIENCE PRESS, INC.

Follow UroToday

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free